Alamar Biosciences, Inc. Common Stock ALMR
$28.05
+4.26%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $34.50
- Implied Upside
- +23.0%
- Price Target Range
- $32.00 – $36.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-04 | TD CowenDan Brennan |
Maintains | Buy | $34 → $36 |
| 2026-08-11 | StifelDaniel Arias |
Maintains | Buy | $28 → $32 |
| 2026-08-11 | JP MorganCasey Woodring |
Maintains | Overweight | $32 → $35 |
| 2026-05-12 | Leerink PartnersPuneet Souda |
Initiates coverage on | Outperform | $35 |
| 2026-05-12 | TD CowenDan Brennan |
Initiates coverage on | Buy | $30 |
| 2026-05-12 | JP MorganCasey Woodring |
Initiates coverage on | Overweight | $30 |
| 2026-05-12 | StifelDaniel Arias |
Initiates coverage on | Buy | $28 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $28.05
- Market Cap
- $1.95 billion
- 52-Week Range
- $18.84 – $39.61
- Average Volume
- 808K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.